España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
CSL
CSLLY
OTCQX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$88.56
-0.19
-0.21%
At close: -
Get Report
Comment
CSL (CSLLY) Forecast
News
Earnings
CSL (CSLLY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for CSL (OTC:CSLLY) Stock
CSL Stock (OTC: CSLLY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, October 07, 2024
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Friday, October 04, 2024
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Vandana Singh
U.S. HHS Official Says BARDA Awarding Additio...
Benzinga Newsdesk
Monday, September 30, 2024
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Vandana Singh
Thursday, July 11, 2024
Akebia And CSL Vifor Have Terminated The Lice...
Benzinga Newsdesk
Tuesday, July 02, 2024
US HHS Says 8 Labs Sign Royalty-Free Agreemen...
Benzinga Newsdesk
Monday, May 20, 2024
CSL and Arcturus Therapeutics Announce Nature...
Benzinga Newsdesk
Tuesday, April 30, 2024
ARS Pharmaceuticals Submits Response For neff...
Benzinga Newsdesk
Friday, April 26, 2024
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Vandana Singh
Friday, February 23, 2024
Travere Therapeutics And CSL Vifor Announced ...
Benzinga Newsdesk
Wednesday, December 13, 2023
Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
Vandana Singh
Monday, March 20, 2023
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Vandana Singh
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Vandana Singh
Tuesday, February 21, 2023
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
Vandana Singh
Wednesday, November 23, 2022
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Vandana Singh
Wednesday, November 02, 2022
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
Vandana Singh
Monday, August 22, 2022
Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
Vandana Singh
Wednesday, August 17, 2022
CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks
Vandana Singh
Friday, May 13, 2022
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Vandana Singh
Tuesday, December 14, 2021
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
Vandana Singh
Wednesday, March 03, 2021
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Vandana Singh
Sunday, November 08, 2020
CSL Announced Commencement of Manufacturing of University of Oxford/AstraZeneca Vaccine Candidate in Melbourne
Charles Gross
Tuesday, March 24, 2020
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Wednesday, February 19, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Wednesday, February 12, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Tuesday, February 11, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Thursday, February 06, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Tuesday, February 04, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Wednesday, January 29, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Friday, January 24, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Wednesday, January 22, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Tuesday, January 21, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Thursday, January 16, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Friday, January 10, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Thursday, January 09, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Monday, December 02, 2019
Stocks That Hit 52-Week Highs On Monday
Lisa Levin
Friday, November 29, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Wednesday, November 27, 2019
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Tuesday, November 26, 2019
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Friday, October 11, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
